jump to search | jump to navigation

Small molecule alliance

08.07.10 Turku – Finland’s Faron Pharmaceuticals Ltd. has announced a cooperation with German biotech company Priaxon AG to create new scaffold structures to modify the AOC3-protein function and its ligand interaction with orally... more
 

Short people higher risk of heart disease than tall people

09.06.10 Tampere – Short people are at greater risk of developing heart disease than tall people, according to a meta-analysis of 52 populations-based studies including 3 million people by Finnish researchers (Eur. Heart J.,... more
 

Genes play a role in lighting up

12.05.10 Reykjavik – Researchers from the Icelandic bio­tech company deCODE – together with colleagues from 23 institutions in a dozen countries – have determined that genetic factors influence both nico­tine dependence and the incidence... more
 

Safety in focus

11.05.10 Turku – Finnish Biotie Therapies Corp. confirmed that its oral phospho­diesterase 4 inhibitor ELB353 has proven safe and pharmacologically active in a Phase I study. Pharmacokinetic data point to the suitability of ELB353 for a... more
 

Linking up: EU biobank synergies

07.03.10 Helsinki/Hinxton – Finland has pledged EUR1.85m to help create world-class bio­informatics, biobanking and translational research infrastructures, the European Bioinformatics Institute (EBI) at the European Molecular Laboratory... more
 
Displaying results 1 to 5 out of 80

First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Next Last

Metanavigation